Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2005 Apr 1;115(4):1100. doi: 10.1172/JCI200522996C1

Toll-like receptor 9–induced type I IFN protects mice from experimental colitis

Kyoko Katakura, Jongdae Lee, Daniel Rachmilewitz, Gloria Li, Lars Eckmann, Eyal Raz
PMCID: PMC1070411

Original citation: J. Clin. Invest. 115:695–702(2005). doi:10.1172/JCI200522996

Citation for this corrigendum: J. Clin. Invest. 115:1100 (2005). doi:10.1172/JCI200522996C1

Reference number 24 was incorrect. The corrected reference should read:

Ishii, K.J., et al. 2002. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196:269–274.

The authors regret the error.


Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES